BIOMAT Database Logo BIOMAT Database Logo

Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate. 1990

D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Manchester Skin Hospital, University of Manchester School of Medicine, Salford, U.K.

The serum level of the aminoterminal peptide of type III procollagen (P3NP) was measured in 51 psoriatic patients on long-term, once weekly, low-dose methotrexate and in a control group of patients with extensive psoriasis who had never had systemic treatment. Serum P3NP levels were normal in all control patients, but were elevated in the majority of methotrexate-treated patients, even those with normal or non-specific liver histology. Although the highest P3NP values were found in the groups of patients with fibrosis and cirrhosis, isolated P3NP measurements did not discriminate between individuals with and without significant liver pathology. Neither standard nor dynamic liver function tests were able to identify patients with significant liver damage and in most cases results were in the normal range.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Elevated serum aminoterminal procollagen type III peptide in methotrexate-induced hepatic fibrosis.
April 1986, The British journal of dermatology,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
[Serum type III procollagen peptide in tissue fibrosis].
January 1985, Rinsho byori. The Japanese journal of clinical pathology,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
March 2005, The British journal of dermatology,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis.
December 1985, Gastroenterologia Japonica,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis.
March 1992, Journal of the American Academy of Dermatology,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.
July 1986, Digestive diseases and sciences,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Enzyme-linked immunosorbent assay for serum procollagen type III peptide in rats with hepatic fibrosis.
November 1998, The Journal of veterinary medical science,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
September 1988, The British journal of dermatology,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
July 1991, Journal of the American Academy of Dermatology,
D Mitchell, and A Smith, and B Rowan, and T W Warnes, and N Y Haboubi, and S B Lucas, and R J Chalmers
Serum concentration of N-terminal procollagen peptide of collagen type III in schistosomal liver fibrosis.
June 1987, Experimental and molecular pathology,
Copied contents to your clipboard!